Top of this page
Skip navigation, go straight to the content

ucb-usa.com Newsroom UCB U.S. News

Categories

Magazine

  • Press Release: UCB Presents New Data From Rheumatology Portfolio Addressing Unmet Needs in Axial Spondyloarthritis, Psoriatic Arthritis and Lupus at 2019 ACR/ARP

    UCB_LOGO_1280x960
    UCB Presents New Data From Rheumatology Portfolio Addressing Unmet Needs in Axial Spondyloarthritis, Psoriatic Arthritis and Lupus at 2019 ACR/ARP

    Read more

  • What You See Is What You Get

    DenelleWaynick Quote Headshot BlogPost
    UCB's Denelle Waynick, VP, Legal Affairs (U.S.), U.S. General Counsel and Global Head, Enterprise Risk Management, leads by example by being true to herself to encourage others to do so too. Read more from Denelle on why by being authentic to yourself, you become stronger as an individual, leader, and employee. Read the full article on LinkedIn.

    Read more

  • Patients Inspiring Growth at UCB's Bedford Lab

    Jess_1280_960



    UCB researchers like Jessica Williamson, PhD, come to work driven by a singular purpose – to create value for people living with severe disease. That’s because patients depend on the important work of scientific research to discover new medical innovations that will help them achieve their goals. Read more from Dr. Williamson about why she's passionate about innovating for patients and UCB's growing research presence in the greater Boston area.

    Read more

  • Disease Spotlight: Seizure Clusters

    Posted by Erica Puntel, U.S. Communications, Digital
    Seizure_Clusters_1280_x_960_n_2
    At UCB, we keep patients at the center - inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. We have a rich heritage in epilepsy, and today, we’re shining a spotlight on seizure clusters, which can affect people with uncontrolled epilepsy, to help spread awareness.

    Read more

  • Infographic: Seizure Clusters

    Posted by Erica Puntel, U.S. Communications, Digital
    Seizure_Clusters_1280_x_960_n_2
    At UCB, we keep patients at the center - inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. We have a rich heritage in epilepsy, and today, we’re shining a spotlight on seizure clusters, which can affect people with uncontrolled epilepsy, to help spread awareness. Check out the full infographic below.

    Read more

  • Bimekizumab Phase 3 Psoriasis Study Meets All Endpoints, Achieving Significantly Greater Efficacy Versus Placebo and Ustekinumab

    UCB_LOGO_1280x960
    • The Phase 3 BE VIVID study evaluating the efficacy and safety of bimekizumab in adults with moderate-to-severe chronic plaque psoriasis met all primary and ranked secondary endpointsi

    Read more

  • Finding the Inspiration to Thrive with nr-axSpA

    Chelsea_nr axspa_1280_960
    Learn more about living with non-radiographic axial spondyloarthritis (nr-axSpA) from Chelsea, who recently shared her story.

    Read more

  • UCB agrees to acquire Ra Pharmaceuticals: Joining forces to improve treatment options for people living with myasthenia gravis and other rare diseases

    UCB_LOGO_1280x960
    • Will enhance UCB’s leadership potential in myasthenia gravis by adding zilucoplan, a peptide inhibitor of complement component 5 (C5) currently in phase 3, to the UCB pipeline alongside to UCB’s rozanolixizumab, an FcRn targeting antibody also in phase 3

    Read more

  • It’s Time to Come Together to Deliver More for Patients

    UCB JeanChristophe Blog 1
    At UCB, we keep patients at the center of everything we do, inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. Read more from UCB's CEO and Chairman of the Executive Committee, Jean-Christophe Tellier, about why it's time to come together across all healthcare stakeholders to deliver more for patients.

    Read more

  • UCB PharmD Fellows Have a Big Impact on Patients

    Posted by Katelyn Snider, U.S. Communications & Public Affairs
    Regulatory_Fellows_for_Blog_1280_960
    UCB Global Regulatory Affairs Fellows (L to R): Howraa Alasker, PharmD and Tanya Chaudhri, PharmD, RPh

    The 2020-2022 UCB Global Regulatory Affairs (GRA) PharmD Fellowship Program, a collaboration with the Industry Pharmacists Organization (IPhO), is a 2-year rotational program located at UCB’s Atlanta campus aimed at growing top regulatory talent for the future. Established in 2017, the Fellowship Program is designed to provide PharmD graduates with the opportunity to learn and experience all aspects of regulatory affairs under the mentorship of experienced preceptors. Applications are being accepted now until November 1, 2019. Learn more about the fellowship from current fellow, Tanya Chaudhri, PharmD, RPh.

    Read more